Carcinomas of an unknown primary site: A curable disease?

Annals of Oncology

Volumn 19, Issue 9, 2008, Pages 1657-1658

  Levy, A ^a   Massard, C ^a   Gross Goupil, M ^a   Fizazi, K ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CISPLATIN; CYTOKERATIN ANTIBODY; ETOPOSIDE; GEMCITABINE;

ADENOCARCINOMA; ARTICLE; BONE CANCER; BONE LESION; CANCER CHEMOTHERAPY; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NODULE; LYMPH NODE BIOPSY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; REPEATED DRUG DOSE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; WHOLE BODY CT;

ADENOCARCINOMA; BIOPSY, NEEDLE; BONE NEOPLASMS; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; TREATMENT OUTCOME;

EID: 50849121351     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn430     Document Type: Article

References (5)

1. Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 2005; 54: 243-250.
2. Lenzi R, Hess KR, Abbruzzese JL et al. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: Favorable subsets of patients with unknown-primary carcinoma? J Clin Oncol 1997; 15: 2056-2066.
3. Fizazi K. Treatment of patients with specific subsets of carcinoma of an unknown primary site. Ann Oncol 2006; 17: 177-180.
4. Culine S, Kramar A, Fizazi K et al. Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. French Study Group on Carcinomas of Unknown Primary. J Clin Oncol 2002; 15(20): 4679-4683.
5. Hess KR, Abbruzzese MC, Abbruzzese JL et al. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res 1999; 5: 3403-3410.